Where Your News Is Made.
Reach your press release and disclosure targets.
Get more views with multimedia.
Track your results and refine your message.
Be the news everyone talks about.
Latest News
Today is February 23, 2019.
All times in Eastern Time.
-
Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer
PRINCETON, N.J.--(BUSINESS WIRE)--Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer more » -
Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
PRINCETON, N.J.--(BUSINESS WIRE)--Opdivo Plus Low-Dose Yervoy Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or .... more » -
European Commission Approves Bristol-Myers Squibb’s Sprycel (dasatinib) in Combination with Chemotherapy for Treatment of Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
PRINCETON, N.J.--(BUSINESS WIRE)--European Commission Approves BMS’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients with Newly Diagnosed Philadelphia... more » -
Bristol-Myers Squibb to Take Part in Guggenheim Healthcare Talks Idea Forum
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Take Part in Guggenheim Healthcare Talks Idea Forum more » -
Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call more » -
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results more »